Skip to main content

Table 2 Comparison of the clinico-pathologic features of our case with other cases reported

From: Mammary mucinous cystadenocarcinoma with long-term follow-up: molecular information and literature review

Number

Cases

Patient profile

Tumor size (cm)

pN

ER

PR

HER2

Ki-67

CK7

CK20

Associated Findings

Surgery; CT/RT/HT

Follow-up (FU)

1

Rosen PP et al.[22]

79 years; F

6.0

NA

_

_

NA

NA

NA

NA

NA

M, LND

9 years + 

2

Tavasolli et al.[2]

54 years; F

19.0

N2

_

_

NA

40%

 + 

_

none

M, LND

24 months ANED

3

 

67 years; F

2.3

N0

_

_

NA

30%

 + 

_

DCIS

M, LND

22 months ANED

4

 

49 years; F

8.5

N0

_

_

NA

70%

 + 

_

DCIS

M, LND, CT + RT

11 months ANED

5

 

61 years; F

0.8

N0

_

_

NA

50%

 + 

_

none

Lumpectomy, LND

NA

6

Domoto H, et al.[6]

74 years; F

10.0

N0

_

_

_

22%

 + 

_

NA

M, LND,

2 years, ANED

7

Naoko H et al.[20]

96 years; F

2.0

N1

_

_

_

35%

NA

NA

none

Lumpectomy, LND

46 months + 

8

Chen et al.[27]

65 years; F

3.0

N0

_

_

_

NA

 + 

_

IDC, DCIS

M, LND, CT

8 months, ANED

9

Coyne JD et al.[3]

51 years; F

4.0

N0

_

_

NA

NA

 + 

_

NA

Lumpectomy,

NA

10

Lee et al.[15]

55 years; F

2.5

N0

_

_

_

10%

 + 

_

IDC, DCIS

M, LND

6 months, ANED

11

Rakici et al.[24]

52 years; F

10.0

N0

 + 

_

_

NA

_

_

ADH

M, LND, HT

24 months, ANED

12

Lin et al.[5]

61 years; F

3.0

N0

_

_

_

NA

NA

_

none

M, LND

6 months, ANED

13

Petersson et al.[23]

73 years; F

4.5

N0

_

_

2 + (FISH +)

NA

 + 

_

DCIS

M, LND

NA

14

Sentani et al.[25]

65 years; F

3.0

N0

_

_

NA

NA

 + 

_

DCIS

Lumpectomy, LND

6 months, ANED

15

Witherspoon et al.[28]

91 years; F

7.5

N0

_

_

_

40%

 + 

_

IDC, DCIS

Lumpectomy, LND, RT

14 months, ANED

16

Deng et al.[4]

41 years; F

7.0, 5.0, 2.5

N3

_

_

_

50%

 + 

_

DCIS

M, LND

24 months, ANED

17

Li et al.[16]

52 years; F

6.5

N0

_

_

_

10%

 + 

_

none

NA

NA

18

Kim et al.[12]

59 years; F

0.9

N0

_

_

2 + (FISH -)

5%

 + 

_

IDC, DCIS

Lumpectomy, LND, CT

3 months, ANED

19

Koufopoulos et al.[13]

63 years; F

1.6

N2

_

_

_

NA

 + 

_

none

M, LND

48 months, ANED

20

Lin et al.[17]

62 years; F

5.6

N0

_

_

_

NA

 + 

_

none

M, LND

5 months, ANED

21

Kucukzeybek et al.[14]

55 years; F

2.0

N0

_

_

2 + (FISH +)

30%

 + 

_

DCIS

M, LND, CT, RT, trastuzumab

NA

22

Seong et al.[26]

59 years; F

2.0

NA

_

_

3 + 

NA

NA

NA

NA

NA

NA

23

 

50 years; F

2.2

NA

_

_

_

NA

NA

NA

NA

NA

NA

24

Nayak et al.[21]

68 years; F

6.2

N0

_

_

_

NA

 + 

_

DCIS

M, LND

3 months, ANED

25

 

51 years; F;

2.0

N1

_

_

_

NA

 + 

_

DCIS

M, LND

8 years, recurrence

26

Kaur et al.[11]

45 years; F

12.0

NA

_

_

_

NA

 + 

_

none

M

NA

27

Wang et al.[29]

66 years; F

2.5

N0

_

_

_

60%

 + 

_

DCIS

NA

10 months, ANED

28

Sun et al.[19]

56 years; F

1.0, 1.5, 1.2, 2.0

N0

 + 

 + 

1 + 

3%-5%

_

_

lobular lesions

M, LND, HT

3 years, ANED

29

Lin et al.[18]

72 years; F

0.9

N0

_

_

_

30%

 + 

_

none

M, LND, RT

16 months, ANED

30

Kamrani et al.[9]

69 years; F

2.0

N0

_

_

_

NA

NA

NA

DCIS

M

NA

31

Ekta et al.[8]

45 years; F

4.3

N0

_

_

_

45%-50%

 + 

 + 

DCIS

M, LND, CT

NA

32

Kaur et al.[10]

65 years; F

18.0

N0

_

_

3 + 

90%

 + 

focal + 

none

M

6 months, ANED

33

Present case

59 years; F;

3.0

N0

_

_

_

40%

 + 

_

NA

M, LND, CT

108 months, ANED

  1. Abbreviation: F Female, NA Not available, CT Chemotherapy, RT Radiotherapy, HT Hormonotherapy, ANED Alive with no evidence of disease, M Mastectomy, LND Lymph node dissection,  + Died of disease other than carcinoma, PN Pathology lymph node, ER Estrogen receptor, PR Progestogen receptor, HER2 Human epidermal growth factor 2, FISH Fluorescence in situ hybridization, IDC Invasive ductal carcinoma, DCIS Ductal carcinoma in situ